Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

14.54
Delayed Data
As of 3:59pm ET
 +0.47 / +3.34%
Today’s Change
9.16
Today|||52-Week Range
17.55
-13.71%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close14.07
Today’s open14.21
Day’s range13.89 - 14.59
Volume897,622
Average volume (3 months)1,520,041
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-52.93%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book296.09

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.11-1.36%
DBVTDBV Technologies SA+1.23+3.99%
INCRINC Research Holding...+0.74+1.68%
LXRXLexicon Pharmaceutic...-0.44-3.29%
Data as of 3:59pm ET, 05/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs